Jane Street Group, LLC Allogene Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$2.08 - $3.5 $27,040 - $45,500	13,000 New	13,000 $36,000
Q1 2022 May 17, 2022	SELL	$7.65 - $15.29 $259,335 - $518,331	-33,900 Reduced 63.48%	19,500 $178,000
Q4 2021 Feb 15, 2022	BUY	$13.13 - $24.52 $464,802 - $868,008	35,400 Added 196.67%	53,400 $797,000
Q3 2021 Nov 16, 2021	BUY	$21.01 - $27.64 $210,100 - $276,400	10,000 Added 125.0%	18,000 $463,000
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $77,517 - $118,139	3,300 Added 70.21%	8,000 $209,000
Q2 2020 Aug 17, 2020	BUY	$18.39 - $54.04 $86,433 - $253,988	4,700 New	4,700 $201,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.